We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Collaboration Is the X Factor in Making Precision Medicine a Success
Blog

Companion diagnostics (CDx), i.e. in vitro medical devices, and next-generation sequencing (NGS), are both essential to the practice of precision medicine. As new regulations are introduced, pharma companies and manufacturers alike need to ensure their CDx processes are compliant or we could see a deceleration in the flow of new precision therapies in the near future.

Read More

Synthesis Innovation in Drug Discovery
Blog

We recently had the pleasure of speaking with Danica Rankic, Associate Principal Scientist, MSD to learn more about their process chemistry activities. She touches on the synthesis strategies impacting drug discovery and provides a snapshot of her upcoming talk, taking place December, 2019.

Read More

Fuelling Innovation in UK Life Sciences
Blog

We spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.

Read More

Therapeutically Targeting the Interconnected Biology of the Gut
Blog

We recently had the pleasure of interviewing Paul-Peter Tak, CEO of Kintai Therapeutics. Tak discusses how Kintai Therapeutics are exploiting the power of big data and machine learning to unravel the interconnected biology of the gut, and explains how the enteric signaling network can be therapeutically targeted.

Read More

Translational Research in Clinical Proteomics
Blog

In this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.

Read More

Building a Community to Change Biology for the Better
Blog

Biological complexity is not getting any easier to unravel but utilizing the power of computers could make us better at it.

Read More

Method “Matches” Medicines to Their Unique Protein Receptors
Blog

A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.

Read More

A Conversation on the "Latest and Greatest" in Metabolomics
Blog

Aided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".

Read More

Life Science Technology Megatrends Shaping Our Future
Blog

Megatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.

Read More

Applying Precision Genomics in Biopharma Drug Development
Blog

A recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.

Read More